A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-016-3092-9
Published Online: 2016-06-23
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okuma, Yusuke http://orcid.org/0000-0001-5743-0149
Hosomi, Yukio
Takahashi, Satoshi
Nakahara, Yoshiro
Watanabe, Kageaki
Nagamata, Makoto
Takagi, Yusuke
Mikura, Shinichiro
License valid from 2016-06-23